arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Kodiak Sciences Inc

KOD Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$31.05
▼ -9.1% Today
as of Jun 7, 07:19 ET
Last 30 days -31.65% Apr 28 → Jun 05
$29.86 $34.17 $38.47 $42.77 $47.08 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$34.00
High
$34.81
Low
$30.08
Volume
$1M
Avg Vol
$836,618
Mkt Cap
$2.3B
P/E (TTM)
Beta
52w High
$47.84
52w Low
$3.43
Div Yield
Shares Out
$62M

Overview

52-week range
$3.43
$48
62% of range
Avg surprise (last 2)
-11.8%
Avg reaction (last 2)
-3.5%
0% positive
Latest IV / EM
96%
EM ±13.4% · $31 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.53$-1.35$-1.18$-1.00$-0.82 Actual $-1.53Actual $-0.95Actual $-0.82Actual $-0.86Actual $-0.84Actual $-1.09Est $-0.89Actual $-1.03Actual $-1.16Actual $-0.94Est $-0.93 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-61M$-58M$-54M$-50M$-46M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.94 $-0.93 -1.1% +13.8% -4.8% earnings
Tue Sep 30, 2025Sep 2025 $-1.16 financials
Mon Jun 30, 2025Jun 2025 $-1.03 financials
Wed May 14, 2025Mar/2025 $-1.09 $-0.89 -22.5% -2.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.84 financials
Sun Jun 30, 2024Jun 2024 $-0.86 financials
Sun Mar 31, 2024Mar 2024 $-0.82 financials
Sat Sep 30, 2023Sep 2023 $-0.95 financials
Fri Jun 30, 2023Jun 2023 $-1.53 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-60M$-62M$-56M$-59M$-47M$-48M
Net income$-58M$-61M$-54M$-57M$-44M$-45M
EPS (diluted)$-0.94$-1.16$-1.03$-1.09$-0.84$-0.86

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$170M$210M$72M$104M$139M$168M$198M$219M
Inventory
Total current assets$175M$215M$76M$108M$143M$172M$202M$225M
Total assets$306M$352M$218M$257M$298M$336M$373M$402M
Long-term debt
Total liabilities$194M$194M$194M$186M$189M$185M$187M$187M
Total equity$112M$157M$24M$70M$109M$150M$185M$215M

Implied volatility — last 90 days

91%93%96%98%101% Jun 07 — IV 96% · EM ±13.4%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.